Featured Research

from universities, journals, and other organizations

New Research Identifies Human Enzyme That Could Be Programmed To Kill Cancer Cells

Date:
December 29, 2006
Source:
Children's Hospital & Research Center at Oakland
Summary:
A new study conducted by scientists at Children's Hospital Oakland Research Institute (CHORI) identifies a specific enzyme that can cause the death of cancer cells. Researchers studied the behavior of an enzyme called sphingosine phosphate lyase (SPL), which can regulate cell growth and death by lowering the levels of a natural, growth-promoting lipid called sphingosine-1-phosphate, or S1P.

A new study conducted by scientists at Children's Hospital Oakland Research Institute (CHORI) identifies a specific enzyme that can cause the death of cancer cells. Researchers studied the behavior of an enzyme called sphingosine phosphate lyase (SPL), which can regulate cell growth and death by lowering the levels of a natural, growth-promoting lipid called sphingosine-1-phosphate, or S1P.

The study, led by Julie Saba, M.D., Ph.D. is the first to link the SPL enzyme to cancer, and it appears in the November issue of the Proceedings of the National Academy of Sciences. Researchers identified SPL as a key regulator of cancer cells. They discovered that if the cancer cells were stressed by chemotherapy, SPL could be activated or "turned on" to reduce the levels of S1P, which is needed to cause cell death. "The enzyme SPL senses when a cell has sustained damage or is undergoing mutations," said Dr. Saba. "Once the enzyme is aware of these changes it responds by killing the cell. We hope to find new ways to leverage the body's own natural responses to these mutated or damaged cells to target cancer cells."

Among pediatric diseases, cancer is the leading cause of death in the United States. Approximately 9,500 new cases of cancer are expected to occur in children between infancy and 15 years of age by the end 2006.* "Although we're beginning our studies in colon cancer, we believe our research findings will have a direct impact on investigations for other cancers, including pediatric cancers," said Dr. Saba. "It is premature to suggest that SPL is the answer to curing cancer, but our research findings should dramatically advance our search for a cure," said Dr. Saba.

Dr. Saba and her team conducted their year-long research by studying a number of different human cell lines as well as human colon cancer tissues and mouse intestinal polyps. They wanted to see what happens when you increase or decrease the activity of SPL in human cells. Their research found the enzyme makes cancer cells more vulnerable to chemotherapy, whereas removing the enzyme makes the cells more resistant to treatment. They also found that the enzyme is inactive in colon cancers and mouse polyps, but very active in nearby healthy tissues. This suggests that reactivation of SPL could be used to improve cancer therapies by increasing the number of cancer cells killed by chemotherapy.

*Surveillance, Epidemiology, and End Results (SEER) Program and the American Cancer Society.


Story Source:

The above story is based on materials provided by Children's Hospital & Research Center at Oakland. Note: Materials may be edited for content and length.


Cite This Page:

Children's Hospital & Research Center at Oakland. "New Research Identifies Human Enzyme That Could Be Programmed To Kill Cancer Cells." ScienceDaily. ScienceDaily, 29 December 2006. <www.sciencedaily.com/releases/2006/11/061120182022.htm>.
Children's Hospital & Research Center at Oakland. (2006, December 29). New Research Identifies Human Enzyme That Could Be Programmed To Kill Cancer Cells. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2006/11/061120182022.htm
Children's Hospital & Research Center at Oakland. "New Research Identifies Human Enzyme That Could Be Programmed To Kill Cancer Cells." ScienceDaily. www.sciencedaily.com/releases/2006/11/061120182022.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins